File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.bpg.2004.10.003
- Scopus: eid_2-s2.0-14744286203
- PMID: 15757806
- WOS: WOS:000227994200006
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Serological markers of liver cancer
Title | Serological markers of liver cancer |
---|---|
Authors | |
Keywords | Alpha-fetoprotein Des-gamma-carboxyprothrombin Glypican-3 Hepatocellular carcinoma Serological marker |
Issue Date | 2005 |
Publisher | Bailliere Tindall. The Journal's web site is located at http://www.elsevier.com/locate/bpg |
Citation | Best Practice And Research: Clinical Gastroenterology, 2005, v. 19 n. 1 SPEC. ISS., p. 91-99 How to Cite? |
Abstract | Serological markers for hepatocellular carcinoma (HCC) are important for early diagnosis, as well as monitoring of tumour aggressiveness, treatment responsiveness, recurrence and survival. The three most common markers are total alpha-fetoprotein (AFP), Lens culinaris agglutinin-reactive AFP (AFP-L3) and protein induced by vitamin K absence or antagonist-II (PIVKA-II). Total AFP has the sensitivity of 60% and specificity of 90% for the detection of HCC. Increase in the percentage of AFP-L3 over the total AFP (>10%) is very specific for small HCC. PIVKA-II is also more specific than total AFP in detecting HCC. AFP-L3 and PIVKA-II levels correlate with tumour aggressiveness and prognosis. All three markers are useful for monitoring treatment responsiveness and tumour recurrence. Since the levels of the three markers are independent of each other, combination of measurement of two or three markers will increase the sensitivity and diagnostic accuracy. Some novel markers including glypican-3 are being extensively studied. © 2004 Elsevier Ltd. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/78512 |
ISSN | 2023 Impact Factor: 3.2 2023 SCImago Journal Rankings: 1.135 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yuen, MF | en_HK |
dc.contributor.author | Lai, CL | en_HK |
dc.date.accessioned | 2010-09-06T07:43:42Z | - |
dc.date.available | 2010-09-06T07:43:42Z | - |
dc.date.issued | 2005 | en_HK |
dc.identifier.citation | Best Practice And Research: Clinical Gastroenterology, 2005, v. 19 n. 1 SPEC. ISS., p. 91-99 | en_HK |
dc.identifier.issn | 1521-6918 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/78512 | - |
dc.description.abstract | Serological markers for hepatocellular carcinoma (HCC) are important for early diagnosis, as well as monitoring of tumour aggressiveness, treatment responsiveness, recurrence and survival. The three most common markers are total alpha-fetoprotein (AFP), Lens culinaris agglutinin-reactive AFP (AFP-L3) and protein induced by vitamin K absence or antagonist-II (PIVKA-II). Total AFP has the sensitivity of 60% and specificity of 90% for the detection of HCC. Increase in the percentage of AFP-L3 over the total AFP (>10%) is very specific for small HCC. PIVKA-II is also more specific than total AFP in detecting HCC. AFP-L3 and PIVKA-II levels correlate with tumour aggressiveness and prognosis. All three markers are useful for monitoring treatment responsiveness and tumour recurrence. Since the levels of the three markers are independent of each other, combination of measurement of two or three markers will increase the sensitivity and diagnostic accuracy. Some novel markers including glypican-3 are being extensively studied. © 2004 Elsevier Ltd. All rights reserved. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Bailliere Tindall. The Journal's web site is located at http://www.elsevier.com/locate/bpg | en_HK |
dc.relation.ispartof | Best Practice and Research: Clinical Gastroenterology | en_HK |
dc.subject | Alpha-fetoprotein | - |
dc.subject | Des-gamma-carboxyprothrombin | - |
dc.subject | Glypican-3 | - |
dc.subject | Hepatocellular carcinoma | - |
dc.subject | Serological marker | - |
dc.subject.mesh | Biological Markers - blood | en_HK |
dc.subject.mesh | Glypicans | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Liver Neoplasms - diagnosis | en_HK |
dc.subject.mesh | Membrane Proteins - blood | en_HK |
dc.subject.mesh | Neoplasm Proteins - blood | en_HK |
dc.subject.mesh | Plant Lectins | en_HK |
dc.subject.mesh | Protein Precursors - blood | en_HK |
dc.subject.mesh | Prothrombin | en_HK |
dc.subject.mesh | Sensitivity and Specificity | en_HK |
dc.subject.mesh | Serologic Tests | en_HK |
dc.subject.mesh | Tumor Markers, Biological - blood | en_HK |
dc.subject.mesh | alpha-Fetoproteins - analysis | en_HK |
dc.title | Serological markers of liver cancer | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1521-6918&volume=19&issue=1&spage=91&epage=9&date=2005&atitle=Serological+markers+of+liver+cancer. | en_HK |
dc.identifier.email | Yuen, MF:mfyuen@hkucc.hku.hk | en_HK |
dc.identifier.email | Lai, CL:hrmelcl@hku.hk | en_HK |
dc.identifier.authority | Yuen, MF=rp00479 | en_HK |
dc.identifier.authority | Lai, CL=rp00314 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.bpg.2004.10.003 | en_HK |
dc.identifier.pmid | 15757806 | - |
dc.identifier.scopus | eid_2-s2.0-14744286203 | en_HK |
dc.identifier.hkuros | 101370 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-14744286203&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 19 | en_HK |
dc.identifier.issue | 1 SPEC. ISS. | en_HK |
dc.identifier.spage | 91 | en_HK |
dc.identifier.epage | 99 | en_HK |
dc.identifier.isi | WOS:000227994200006 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Yuen, MF=7102031955 | en_HK |
dc.identifier.scopusauthorid | Lai, CL=7403086396 | en_HK |
dc.identifier.issnl | 1521-6918 | - |